CRC
GOSS icon

Curi RMB Capital’s Gossamer Bio GOSS Stock Holding History

Curi RMB Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55K Buy
39,784
+2,547
+7% +$711 ﹤0.01% 900
2026
Q1 		$12.2K Buy
37,237
+26,566
+249% +$41.8K ﹤0.01% 867
2025
Q4 		$33.1K Buy
+10,671
New +$30.4K ﹤0.01% 873

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Curi RMB Capital's GOSS Position: Q2 2026 in Review

Curi RMB Capital increased its Gossamer Bio (GOSS) stake by 6.8% in Q2 2026, buying an estimated $711 and bringing the position to 39,784 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Curi RMB Capital first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.1K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Curi RMB Capital held 39,784 shares of Gossamer Bio worth $6.55K as of Q2 2026.
  • Curi RMB Capital bought 2,547 Gossamer Bio shares in Q2 2026, an estimated $711.
  • Gossamer Bio made up ﹤0.01% of Curi RMB Capital's portfolio in Q2 2026, its #900 holding.
  • Curi RMB Capital first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Curi RMB Capital's Gossamer Bio position peaked at $33.1K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.